Autolus Therapeutics (AUTL) News Today → Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (From American Alternative) (Ad) Free AUTL Stock Alerts $4.21 -0.27 (-6.03%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAbstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCOglobenewswire.com - April 24 at 10:00 AMAutolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024globenewswire.com - April 23 at 7:00 AMAutolus Therapeutics (NASDAQ:AUTL) Trading Down 5.2%americanbankingnews.com - April 21 at 5:40 AMRSI Alert: Autolus Therapeutics (AUTL) Now Oversoldnasdaq.com - April 21 at 12:59 AMAutolus Therapeutics (NASDAQ:AUTL) Trading Up 3.7%americanbankingnews.com - April 20 at 6:16 AMAutolus Therapeutics (NASDAQ:AUTL) Shares Down 5.2% marketbeat.com - April 19 at 3:27 PMAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $4.86americanbankingnews.com - April 19 at 5:36 AMAutolus Therapeutics (NASDAQ:AUTL) Trading 3.7% Higher marketbeat.com - April 18 at 12:59 PMBuy Rating on Autolus Therapeutics: Innovative Cancer Treatments and Strategic Leadership Drive Positive Outlookmarkets.businessinsider.com - April 12 at 2:50 PMAutolus Therapeutics (NASDAQ:AUTL) Stock Rating Reaffirmed by Needham & Company LLCmarketbeat.com - April 12 at 8:24 AMAutolus Therapeutics (NASDAQ:AUTL) Trading Up 3.3%marketbeat.com - April 11 at 1:48 PMTruist raises Autolus Therapeutics stock target on market lead potentialinvesting.com - April 9 at 10:08 PMAutolus Therapeutics (NASDAQ:AUTL) Given New $11.00 Price Target at Truist Financialmarketbeat.com - April 9 at 2:17 PMAutolus Therapeutics (NASDAQ:AUTL) Stock Price Down 3.6%marketbeat.com - April 8 at 2:28 PMAutolus Therapeutics (NASDAQ:AUTL) Trading Up 4.9%marketbeat.com - April 4 at 2:24 PMAutolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)finance.yahoo.com - April 2 at 8:03 AMAutolus Therapeutics (NASDAQ:AUTL) Trading Down 7.5%marketbeat.com - April 1 at 3:29 PMAutolus Therapeutics Announces Changes to its Board of Directorsglobenewswire.com - April 1 at 7:00 AMAutolus Therapeutics plc (NASDAQ:AUTL) Short Interest Up 13.7% in Marchmarketbeat.com - March 31 at 9:10 PMEuropean Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Tradingmsn.com - March 25 at 1:11 PMAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $6.32marketbeat.com - March 25 at 11:55 AMAutolus Therapeutics (NASDAQ:AUTL) Trading Down 4.6%marketbeat.com - March 21 at 6:43 PMAutolus Therapeutics (NASDAQ:AUTL) Trading 4.5% Higher marketbeat.com - March 20 at 2:21 PMAutolus Therapeutics' (AUTL) Buy Rating Reaffirmed at Needham & Company LLCmarketbeat.com - March 18 at 5:10 PMAutolus Therapeutics (NASDAQ:AUTL) Price Target Increased to $10.00 by Analysts at Truist Financialmarketbeat.com - March 18 at 2:54 PMBreaking Down Autolus Therapeutics: 4 Analysts Share Their Viewsmarkets.businessinsider.com - March 18 at 12:41 PMAutolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 17 at 10:14 AMAutolus Therapeutics plc (NASDAQ:AUTL) Sees Significant Decline in Short Interestmarketbeat.com - March 16 at 12:04 PMBuy Rating Affirmed for Autolus Therapeutics Amid Strong Progress and Potential of Obe-celmarkets.businessinsider.com - March 15 at 1:23 PMQ4 2023 Autolus Therapeutics PLC Earnings Callfinance.yahoo.com - March 15 at 8:23 AMAutolus Therapeutics Full Year 2023 Earnings: EPS Misses Expectationsfinance.yahoo.com - March 15 at 8:23 AMAutolus Therapeutics plc: Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updatesfinanznachrichten.de - March 15 at 1:18 AMAutolus Therapeutics FY 2023 Earnings Previewmsn.com - March 15 at 1:18 AMAnalysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Coherus Biosciences (CHRS) and Autolus Therapeutics (AUTL)markets.businessinsider.com - March 14 at 8:17 PMAutolus Therapeutics PLC Reports Full Year 2023 Financial Resultsfinance.yahoo.com - March 14 at 3:17 PMAutolus Therapeutics (NASDAQ:AUTL) Shares Up 11.5%marketbeat.com - March 14 at 1:23 PMAutolus Therapeutics plc 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - March 14 at 12:20 PMAutolus Therapeutics GAAP EPS of -$1.20 misses by $0.10, revenue of $1.69M misses by $0.01Mmsn.com - March 14 at 10:16 AMAutolus Therapeutics Reports Full Year 2023 Financial Results and Business Updatesglobenewswire.com - March 14 at 7:00 AMAutolus Therapeutics's Earnings Outlookbenzinga.com - March 13 at 6:47 PMAutolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing siteglobenewswire.com - March 12 at 7:00 AMSchonfeld Strategic Advisors LLC Takes Position in Autolus Therapeutics plc (NASDAQ:AUTL)marketbeat.com - March 12 at 5:17 AMAutolus Therapeutics announces publication in Blood Cancer Journalfinance.yahoo.com - March 11 at 9:34 AMAUTL Jun 2024 10.000 callfinance.yahoo.com - March 9 at 2:04 PMAUTL Mar 2024 2.500 callca.finance.yahoo.com - March 1 at 12:37 AMAutolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024globenewswire.com - February 29 at 7:00 AMAutolus Therapeutics Ltd (AUTL)uk.investing.com - February 29 at 12:42 AMVaxcyte, Inc.edition.cnn.com - February 25 at 12:51 PMAutolus Therapeutics plc - Depositary Receipt () (AUTL) Price Target Increased by 5.27% to 9.86msn.com - February 24 at 10:19 AMAutolus Therapeutics Stock (NASDAQ:AUTL), Analyst Ratings, Price Targets, Predictionsbenzinga.com - February 23 at 1:39 PM Get Autolus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"... CLICK HERE TO GET YOUR GUIDE NOW AUTL Media Mentions By Week AUTL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUTL News Sentiment▼0.400.44▲Average Medical News Sentiment AUTL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUTL Articles This Week▼83▲AUTL Articles Average Week Get Autolus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: 4D Molecular Therapeutics News Today Tarsus Pharmaceuticals News Today ADMA Biologics News Today Vir Biotechnology News Today Scholar Rock News Today Adaptimmune Therapeutics News Today Kyverna Therapeutics News Today BioCryst Pharmaceuticals News Today Inhibrx News Today Twist Bioscience News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AUTL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autolus Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
